Shaheenah Dawood, MBBCH, MRCP (UK) | Authors



Hormone Receptor–Positive Breast Cancer: The Known and the Unknown

August 10, 2012

Given the current rate of progress in this field, it may not be completely unlikely that women with hormone receptor–positive breast cancer will be cured of this disease in the foreseeable future.

Brain Metastasis in Breast Cancer: Last Barrier to the Cure?

July 12, 2012

The last two decades have seen the development of a variety of novel therapeutic agents that have improved prognoses for women with breast cancer.

Inflammatory Breast Cancer: What Progress Have We Made?

March 15, 2011

Over the past decade, inflammatory breast cancer (IBC), a rare and aggressive subtype of locally advanced breast cancer (LABC), has received much attention at the level of public awareness as well as at the level of research.

Inflammatory Breast Cancer: A Complex Disease

December 01, 2008

In this issue of ONCOLOGY, Houchens and Merajver[3] have commendably attempted to summarize the results of existing research into the molecular determinants of this aggressive disease. The authors have focused specifically on classical prognostic and predictive markers, although these are not specific to the IBC breast tumor subtype.